Personalized management of hyperglycemia in type 2 diabetes: reflections from a Diabetes Care Editors' Expert Forum. - Wikidata - awgldk - TriplyDB

Personalized management of hyperglycemia in type 2 diabetes: reflections from a Diabetes Care Editors' Expert Forum.

Personalized management of hyperglycemia in type 2 diabetes: reflections from a Diabetes Care Editors' Expert Forum.

http://www.wikidata.org/entity/Q39413300

about

Addressing unmet medical needs in type 2 diabetes: a narrative review of drugs under development Insulin resistance as a physiological defense against metabolic stress: implications for the management of subsets of type 2 diabetes A nomogram to estimate the HbA1c response to different DPP-4 inhibitors in type 2 diabetes: a systematic review and meta-analysis of 98 trials with 24 163 patients Alogliptin benzoate for management of type 2 diabetes Comparative risk of major cardiovascular events associated with second-line antidiabetic treatments: a retrospective cohort study using UK primary care data linked to hospitalization and mortality records.Optimal therapy of type 2 diabetes: a controversial challenge Diabetes and cardiovascular disease: from evidence to clinical practice - position statement 2014 of Brazilian Diabetes Society.Mesenchymal stem cell therapy in type 2 diabetes mellitus.Thresholds of oxidative stress in newly diagnosed diabetic patients on intensive glucose-control therapy.Hypoglycaemia, chronic kidney disease and death in type 2 diabetes: the Hong Kong diabetes registry A systematic method for selecting patient-reported outcome measures in diabetes research.A community-based comprehensive intervention program for 7200 patients with type 2 diabetes mellitus in Chongqing (China)The Effect of Comorbidity on Glycemic Control and Systolic Blood Pressure in Type 2 Diabetes: A Cohort Study with 5 Year Follow-Up in Primary Care.Delay in treatment intensification increases the risks of cardiovascular events in patients with type 2 diabetes.Exploring the impact of chronic obstructive pulmonary disease (COPD) on diabetes control in diabetes patients: a prospective observational study in general practice.Allogeneic Mesenchymal Precursor Cells in Type 2 Diabetes: A Randomized, Placebo-Controlled, Dose-Escalation Safety and Tolerability Pilot Study.Clinical action measures improve the reliability of feedback on quality of care in diabetes centres: a retrospective cohort study National estimates of insulin-related hypoglycemia and errors leading to emergency department visits and hospitalizations.Clinical Assessment of Individualized Glycemic Goals in Patients With Type 2 Diabetes: Formulation of an Algorithm Based on a Survey Among Leading Worldwide Diabetologists.Metabolomic biomarkers for personalised glucose lowering drugs treatment in type 2 diabetes.Cardiovascular effects of dapagliflozin in patients with type 2 diabetes and different risk categories: a meta-analysis.Effects of blood pressure on renal and cardiovascular outcomes in Asian patients with type 2 diabetes and overt nephropathy: a post hoc analysis (ORIENT-blood pressure).Insulin therapy in people with type 2 diabetes: opportunities and challenges?Patient-reported outcomes among patients using exenatide twice daily or insulin in clinical practice in six European countries: the CHOICE prospective observational study.Baseline glycemic parameters predict the hemoglobin A1c response to DPP-4 inhibitors : meta-regression analysis of 78 randomized controlled trials with 20,053 patients.One size does not fit all glycemic targets for type 2 diabetes.Dipeptidyl peptidase-4 inhibitors can minimize the hypoglycaemic burden and enhance safety in elderly people with diabetes.Combining clinical judgment with guidelines for the management of type 2 diabetes: overall standards of comprehensive care.Application of clinical judgment and guidelines to achieving glycemic goals in type 2 diabetes: focus on pharmacologic therapy.A short-acting GLP-1 analog or prandial insulin to supplement basal insulin?--Moving toward personalized management of type 2 diabetes mellitus.Oxidative stress as a covariate of recovery in diabetes therapy.Endocrinology research-reflecting on the past decade and looking to the next.Diabetes at the crossroads: relevance of disease classification to pathophysiology and treatment.Effects of Structured Versus Unstructured Self-Monitoring of Blood Glucose on Glucose Control in Patients With Non-insulin-treated Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials.Pharmacogenetics of oral antidiabetes drugs: evidence for diverse signals at the IRS1 locus.Early Combination Therapy with Oral Glucose-Lowering Agents in Type 2 Diabetes.Personalized intensification of insulin therapy in type 2 diabetes - does a basal-bolus regimen suit all patients?Effectiveness of insulin therapy in people with Type 2 diabetes in the Hoorn Diabetes Care System.The interdisciplinary team in type 2 diabetes management: Challenges and best practice solutions from real-world scenarios.Comment on: Raz et al. Personalized management of hyperglycemia in type 2 diabetes: reflections from a Diabetes Care Editors' Expert Forum. Diabetes care 2013;36:1779-1788.

P2860

Q26830274-353DE538-DB7F-43B3-A5C9-044EBBCBEBDF Q26866924-9221DA02-B4DA-46E4-BB78-DBFDD1BF79C5 Q26995462-F4F147E0-4879-42EA-BCC8-998538369718 Q28083933-D2808570-5EBD-49CF-B130-73423ACC640B Q31095975-7F88A8F8-7CE9-4C8B-B719-1A8176209752 Q33577712-F306A626-0BC8-4DFD-A491-D876B03DE6E0 Q33647298-08FB500D-F236-41F8-BD7E-8020C68C1589 Q33691629-433274E6-7EAF-4D4E-A003-93C9848DE0C4 Q33817622-352B5FC5-FE72-4E4B-9DF9-6A80714BF1BB Q34116963-6F651F6B-07E3-4ED8-B371-4B2331267A48 Q34510862-E30FFA5B-0E9B-467A-AD30-0463B95BB947 Q34578336-CFE0A0E7-C074-4102-A66E-4BCE483E7A6B Q35795264-2FEE376E-4C8D-4B4E-BD6E-8F5F8A72B0BA Q35927578-77199B06-E1D9-4787-AB34-0BBF5F51DC81 Q35939395-0A2A53CA-638B-41AC-8A51-328E3DD153E4 Q35973271-59533739-8717-460A-8B2E-5528253010F9 Q36110666-662B24CB-DD88-4119-9284-7BB0482C2954 Q36243180-20C8FD84-68BB-428E-B4FB-82807E014ED1 Q36311665-1DC99C16-17E4-488A-8D32-F71C992CACFF Q36437420-8F8D792F-72C7-4DA0-A380-A5F04A825FD8 Q36599869-94BDD83F-9E57-496D-94F2-5EFF7DE0E5AD Q36603772-BAE2DF94-CB26-4AAB-826E-8B214E92B7A6 Q37461707-BAE24763-441A-4EE3-B48D-EFA76FB89B96 Q37509903-8D99B7E3-B6BF-49AA-BC9E-2FA990420AC3 Q38163894-9F86FB1B-1994-41FF-8D1A-4CAECBBE15AD Q38213052-464FB141-E9B1-45A5-BF24-DCCF8AC30023 Q38215452-4EC80952-B512-4167-9E93-E274A7C43F93 Q38219484-D0F1887B-7B86-4936-9AB7-59B023CB679D Q38219485-111F933C-7411-4785-9967-E2FEECBE0BAC Q38219488-DCE041EF-F8C1-4295-B0CB-6E91F089E31C Q38223754-FDF2D097-45D4-4ED1-86CA-D8BF9F79073F Q38605678-D2E7C11D-5952-470C-A9F5-5E4A60099CF1 Q38615808-C13BD135-E257-4695-8B2F-9DB0C35B0B96 Q38683877-4738AB28-A03D-4865-ABD2-76D60A644F0B Q38684361-F971CA61-5450-423A-983C-20E066DE421D Q38762377-FA294C69-FD88-4F0E-B5FD-5E84A8548520 Q39812306-E5B02D7E-7059-4D7F-AF32-ADBDC03867F6 Q40869844-45585492-346E-4899-B5E0-D460D6255B0B Q42656667-6F4C1513-023A-4B8E-8DE7-75CE83E06180 Q42922528-9DB9D74A-6307-4981-879F-DC9B3ED31A1C

P2860

Personalized management of hyperglycemia in type 2 diabetes: reflections from a Diabetes Care Editors' Expert Forum.

http://www.wikidata.org/entity/Q39413300

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Personalized management of hyp ...... es Care Editors' Expert Forum.

@en

Personalized management of hyp ...... es Care Editors' Expert Forum.

@nl

type

label

Personalized management of hyp ...... es Care Editors' Expert Forum.

@en

Personalized management of hyp ...... es Care Editors' Expert Forum.

@nl

prefLabel

Personalized management of hyp ...... es Care Editors' Expert Forum.

@en

Personalized management of hyp ...... es Care Editors' Expert Forum.

@nl

P1433

Q39413300-FB76FAF6-B22C-45E5-8162-4D60440C77DA

P1476

Q39413300-415A8E5C-E1FE-4B22-8835-2E1A1063037B

P2093

Q39413300-1CF2131A-99A1-46F0-9C3F-02DA2E07515D

Q39413300-277F476E-8AB7-445B-A49C-0B504D058990

Q39413300-3F23908B-E1F7-4236-BFC5-7BD247091AC6

Q39413300-5C98E1CB-CB7B-48A2-968A-76B0696ED1FD

Q39413300-5D6BB0A5-BA48-4172-A145-A89F21BADFD7

Q39413300-B3D63CD3-7ED7-4001-A4C7-86593802B5AC

Q39413300-BD807712-AB8C-41B5-A905-1FC9B7929F1E

Q39413300-BFCA78D5-72E6-4374-A133-0AABE9F55D23

Q39413300-E74CF669-F142-474E-9F7F-EEE9834F8600

P2860

Q39413300-01E526C9-BF40-4232-BEBA-DBE285AAEE07

Q39413300-07871469-1810-431A-948E-10192D60CF5E

Q39413300-16274F60-1656-480A-8104-0F69B66D1062

Q39413300-169EF24D-CA15-43FD-A3A3-A4647518BFD3

Q39413300-1EDBCA3F-A42B-489C-969E-80A38F2E7BD5

Q39413300-260DD398-DA23-4FBD-B57C-7F73339EFD6A

Q39413300-2907663A-C742-45CE-A9DB-BDE33F5215AF

Q39413300-2EED6B28-F71E-41C5-9DB1-CB80F5BCDE0A

Q39413300-3068A625-2127-4180-8B77-CD22F80BCE1F

Q39413300-31894DA2-DB44-4AC9-B7DD-DD8EF833AD54

P304

Q39413300-03B24DFE-2E0A-4BF9-9D52-A72D430A34BB

P31

Q39413300-3B515A6E-C4D1-4DD2-8ED2-6294B2E60394

P356

Q39413300-E3026F07-3712-4E1E-A160-6F02F7E3FA52

P407

Q39413300-05CA3EB7-202D-4DAD-B329-04631DA69EBC

P433

Q39413300-24151FD7-4BC9-4E3A-B587-12F26B821E3F

P478

Q39413300-7A19416A-CE16-4C2A-8D34-650CE0A0470C

P50

Q39413300-2C6DB1A8-0FBE-493F-ABAD-4F4A0F226637

Q39413300-3516EF9E-D06A-47C3-AAAF-B2AC51AFABA3

Q39413300-B34E8BB3-C5C2-48DA-AC85-8FB1BC112A23

Q39413300-DFAE2D37-FF6E-49E5-A53D-3A78A9FB6FC2

P577

Q39413300-6C9629EC-566C-4B14-8719-09FDA57FB915

P5875

Q39413300-5C72E109-2F2F-40B2-BF87-908A8FA033E9

P698

Q39413300-0185D199-D18C-4776-8784-1A680DD833F2

P921

Q39413300-BDB8EEFD-1D23-4177-B14E-C27671A7C46E

Q39413300-EAB24823-DC6D-400F-87EC-3E22184ADE58

P932

Q39413300-55BDF822-FFB9-4E3A-A132-90FDF0969D9F

P356

P1433

P1476

Personalized management of hyp ...... es Care Editors' Expert Forum.

@en

P2093

Derek Leroith

http://www.w3.org/2001/XMLSchema#string

Ele Ferrannini

http://www.w3.org/2001/XMLSchema#string

Itamar Raz

http://www.w3.org/2001/XMLSchema#string

Juliana C N Chan

http://www.w3.org/2001/XMLSchema#string

Lawrence A Leiter

http://www.w3.org/2001/XMLSchema#string

Matthew C Riddle

http://www.w3.org/2001/XMLSchema#string

Philip D Home

http://www.w3.org/2001/XMLSchema#string

Ralph Defronzo

http://www.w3.org/2001/XMLSchema#string

Silvio E Inzucchi

http://www.w3.org/2001/XMLSchema#string

P2860

Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

Standards of medical care in diabetes--2012

Increased risk of acute pancreatitis and biliary disease observed in patients with type 2 diabetes: a retrospective cohort study

Evolutionary conservation predicts function of variants of the human organic cation transporter, OCT1

Diabetes and cancer: a consensus report.

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

Epidemic obesity and type 2 diabetes in Asia

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

Effects of intensive glucose lowering in type 2 diabetes

Personal omics profiling reveals dynamic molecular and medical phenotypes

P304

1779-1788

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DC13-0512

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

36

http://www.w3.org/2001/XMLSchema#string

P50

Stefano Del Prato

Julio Rosenstock

William T. Cefalu

P577

2013-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236909372

http://www.w3.org/2001/XMLSchema#string

P698

23704680

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

P932

3661796

http://www.w3.org/2001/XMLSchema#string